Baader Bank Aktiengesellschaft’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,768
Closed -$1.04M 511
2026
Q1
$1.04M Sell
4,768
-18,596
-80% -$4.63M 0.08% 171
2025
Q4
$5.63M Buy
23,364
+12,947
+124% +$3.31M 0.39% 57
2025
Q3
$2.82M Sell
10,417
-19,394
-65% -$5.3M 0.18% 96
2025
Q2
$7.69M Sell
29,811
-211
-0.7% -$50.3K 0.55% 46
2025
Q1
$6.72M Sell
30,022
-4,220
-12% -$985K 0.5% 52
2024
Q4
$7.83M Sell
34,242
-3,325
-9% -$801K 0.51% 55
2024
Q3
$9.14M Sell
37,567
-950
-2% -$212K 0.53% 56
2024
Q2
$7.36M Buy
38,517
+2,958
+8% +$600K 0.47% 69
2024
Q1
$7.04M Buy
35,559
+8,240
+30% +$1.51M 0.5% 53
2023
Q4
$4.7M Buy
27,319
+25,379
+1,308% +$3.9M 0.34% 66
2023
Q3
$283K Buy
+1,940
New +$351K 0.02% 254

Other funds holding RMD

Baader Bank Aktiengesellschaft's RMD Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft sold out of ResMed (RMD) in Q2 2026, closing a stake of 4,768 shares — an estimated $1.04M sold.

Baader Bank Aktiengesellschaft first reported a position in RMD in Q3 2023 and held it in 11 quarters. The position peaked at $9.14M in Q3 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Baader Bank Aktiengesellschaft reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 4,768 ResMed shares in Q2 2026, an estimated $1.04M.
  • Baader Bank Aktiengesellschaft first reported a position in ResMed in Q3 2023 and held it in 11 quarters.
  • Baader Bank Aktiengesellschaft's ResMed position peaked at $9.14M in Q3 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.